AC T17658
XX
ID T17658
XX
DT 10.03.2005 (created); nvo.
DT 06.04.2010 (updated); lat.
CO Copyright (C), QIAGEN.
XX
FA MR
XX
OS Mammalia
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia
XX
IN T10446 GR; Mammalia.
IN T21552 SRC-1; Mammalia.
XX
DR TRANSPATH: MO000047788.
XX
RN [1]; RE0026655.
RX PUBMED: 10971634.
RA Hansson A. C., Cintra A., Belluardo N., Sommer W., Bhatnagar M., Bader M., Ganten D., Fuxe K.
RT Gluco- and mineralocorticoid receptor-mediated regulation of neurotrophic factor gene expression in the dorsal hippocampus and the neocortex of the rat
RL Eur. J. Neurosci. 12:2918-34 (2000).
RN [2]; RE0031301.
RX PUBMED: 12194973.
RA Planey S. L., Derfoul A., Steplewski A., Robertson N. M., Litwack G.
RT Inhibition of glucocorticoid-induced apoptosis in 697 pre-B lymphocytes by the mineralocorticoid receptor N-terminal domain.
RL J. Biol. Chem. 277:42188-96 (2002).
RN [3]; RE0031526.
RX PUBMED: 9392437.
RA Bruner K. L., Derfoul A., Robertson N. M., Guerriero G., Fernandes-Alnemri T., Alnemri E. S., Litwack G.
RT The unliganded mineralocorticoid receptor is associated with heat shock proteins 70 and 90 and the immunophilin FKBP-52.
RL Recept. Signal Transduct. 7:85-98 (1997).
RN [4]; RE0031903.
RX PUBMED: 14500761.
RA Tallec L. P., Kirsh O., Lecomte M. C., Viengchareun S., Zennaro M. C., Dejean A., Lombes M.
RT Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification.
RL Mol. Endocrinol. 17:2529-42 (2003).
RN [5]; RE0039098.
RX PUBMED: 11518808.
RA Zennaro M. C., Souque A., Viengchareun S., Poisson E., Lombes M.
RT A new human mr splice variant is a ligand-independent transactivator modulating corticosteroid action
RL Mol. Endocrinol. 15:1586-98 (2001).
RN [6]; RE0039461.
RX PUBMED: 11154266.
RA Savory J. G., Prefontaine G. G., Lamprecht C., Liao M., Walther R. F., Lefebvre Y. A., Hache R. J.
RT Glucocorticoid Receptor Homodimers and Glucocorticoid-Mineralocorticoid Receptor Heterodimers Form in the Cytoplasm through Alternative Dimerization Interfaces
RL Mol. Cell. Biol. 21:781-793 (2001).
RN [7]; RE0039493.
RX PUBMED: 8690788.
RA Schulman G., Lindemeyer R., Barman A., Karnik S., Bastl C. P.
RT Atrial natriuretic peptide inhibits mineralocorticoid receptor function in rat colonic surface cells
RL J. Clin. Invest. 98:157-66 (1996).
RN [8]; RE0039507.
RX PUBMED: 12783115.
RA Schafer A., Fraccarollo D., Hildemann S., Christ M., Eigenthaler M., Kobsar A., Walter U., Bauersachs J.
RT Inhibition of platelet activation in congestive heart failure by aldosterone receptor antagonism and ACE inhibition
RL Thromb. Haemost. 89:1024-30 (2003).
RN [9]; RE0039509.
RX PUBMED: 10999937.
RA Auzou G., Fagart J., Souque A., Hellal-Levy C., Wurtz J. M., Moras D., Rafestin-Oblin M. E.
RT A single amino acid mutation of ala-773 in the mineralocorticoid receptor confers agonist properties to 11beta-substituted spirolactones
RL Mol. Pharmacol. 58:684-91 (2000).
RN [10]; RE0042239.
RX PUBMED: 11425909.
RA Gesing A., Bilang-Bleuel A., Droste S. K., Linthorst A. C., Holsboer F., Reul J. M.
RT Psychological stress increases hippocampal mineralocorticoid receptor levels: involvement of corticotropin-releasing hormone
RL J. Neurosci. 21:4822-9 (2001).
XX
//